CR9073A - Coadministracion de tigeciclina y digoxin - Google Patents

Coadministracion de tigeciclina y digoxin

Info

Publication number
CR9073A
CR9073A CR9073A CR9073A CR9073A CR 9073 A CR9073 A CR 9073A CR 9073 A CR9073 A CR 9073A CR 9073 A CR9073 A CR 9073A CR 9073 A CR9073 A CR 9073A
Authority
CR
Costa Rica
Prior art keywords
digoxin
tigecicline
coadministration
tigecycline
administration
Prior art date
Application number
CR9073A
Other languages
English (en)
Inventor
G Raible Donald
Muralidharan Gopal
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of CR9073A publication Critical patent/CR9073A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/65Tetracyclines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)

Abstract

La invencion se relaciona con el tratamiento de infecciones bacterianas con tigeciclina y la insuficiencia cardiaca con digoxin mediante la coadministracion a un humano que lo necesita.
CR9073A 2004-10-28 2007-04-20 Coadministracion de tigeciclina y digoxin CR9073A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62285904P 2004-10-28 2004-10-28

Publications (1)

Publication Number Publication Date
CR9073A true CR9073A (es) 2007-08-28

Family

ID=36127476

Family Applications (1)

Application Number Title Priority Date Filing Date
CR9073A CR9073A (es) 2004-10-28 2007-04-20 Coadministracion de tigeciclina y digoxin

Country Status (18)

Country Link
US (1) US20060094668A1 (es)
EP (1) EP1804807B1 (es)
JP (1) JP2008518911A (es)
KR (1) KR20070069182A (es)
CN (1) CN101039679A (es)
AT (1) ATE415973T1 (es)
AU (1) AU2005310306A1 (es)
BR (1) BRPI0517406A (es)
CA (1) CA2582089A1 (es)
CR (1) CR9073A (es)
DE (1) DE602005011468D1 (es)
EC (1) ECSP077423A (es)
IL (1) IL182681A0 (es)
MX (1) MX2007005163A (es)
NO (1) NO20071706L (es)
RU (1) RU2007112409A (es)
WO (1) WO2006060084A2 (es)
ZA (1) ZA200703441B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102512429A (zh) 2005-03-14 2012-06-27 惠氏公司 替加环素组合物及制备方法
AR055336A1 (es) * 2005-06-16 2007-08-22 Wyeth Corp Proeso de elaboracion para la produccion de tigeciclina como un polvo reconstituible, polvo de tigeciclina liofilizado y producto hecho mediante el proceso
GB2461037A (en) * 2008-06-17 2009-12-23 Elias Bouras A method of treating alopecia using a composition comprising a cardiac glycoside
US20100035845A1 (en) * 2008-08-06 2010-02-11 Wyeth Tigecycline formulations
MY199695A (en) 2017-01-27 2023-11-18 Neurocrine Biosciences Inc Methods for the administration of certain vmat2 inhibitors
DK3684333T3 (da) 2017-09-21 2025-05-12 Neurocrine Biosciences Inc Valbenazin-formulering med høj dosis og sammensætninger, fremgangsmåder og kits relateret hertil
US20200230127A1 (en) 2017-10-10 2020-07-23 Neurocrine Biosciences, Inc. Methods for the Administration of Certain VMAT2 Inhibitors

Also Published As

Publication number Publication date
WO2006060084A3 (en) 2006-07-20
NO20071706L (no) 2007-05-24
BRPI0517406A (pt) 2008-10-07
EP1804807A2 (en) 2007-07-11
ATE415973T1 (de) 2008-12-15
ECSP077423A (es) 2007-05-30
RU2007112409A (ru) 2008-12-10
US20060094668A1 (en) 2006-05-04
IL182681A0 (en) 2007-09-20
AU2005310306A1 (en) 2006-06-08
JP2008518911A (ja) 2008-06-05
EP1804807B1 (en) 2008-12-03
CA2582089A1 (en) 2006-06-08
DE602005011468D1 (de) 2009-01-15
KR20070069182A (ko) 2007-07-02
CN101039679A (zh) 2007-09-19
MX2007005163A (es) 2007-06-26
WO2006060084A2 (en) 2006-06-08
ZA200703441B (en) 2008-09-25

Similar Documents

Publication Publication Date Title
CL2009001099A1 (es) Uso de una muteina de interleuquina-2 humana para el tratamiento y/o prevencion de una enfermedad autoinmune.
CR9073A (es) Coadministracion de tigeciclina y digoxin
CL2016002589A1 (es) Uso del compuesto genz-112638 (eliglustat), inhibidor de glucosilceramida sintasa, en el tratamiento de la enfermedad de gaucher y enfermedad de fabry (divisional de solicitud 201201348).
HRP20110969T1 (en) Pimobendan to be used for the reduction of heart size in mammals suffering from heart failure
CL2008001855A1 (es) Compuestos ciclicos condensados derivados del boro; composicion farmaceutica; y uso en el tratamiento y/o prevencion de una enfermedad infecciosa.
ATE461217T1 (de) Glp-1-verbindungen
CL2009000402A1 (es) Compuestos derivados de 2-amino-acetamida sustituida; composicion farmaceutica; utiles en el tratamiento de enfermedades pulmonares, enfermedad reumatica, enfermedad autoinmune, entre otras.
CL2008002411A1 (es) Compuestos derivados de heterociclos de nitrogenos;composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento de una enfermedad asociada con la miosina del musculo liso o la miosina no muscular, tales como hipertension, enfermedad pulmonar, glaucoma, apoplejia, enfermedades broncocontrictoras, entre otras.
AR109263A2 (es) Composición que comprende moxidectina
ECSP077340A (es) Nuevos derivados de pirimidina y su uso como moduladores del ppar-alfa
CY1110182T1 (el) Ιδεβενονη για τη θεραπεια των μυϊκων δυστροφιων
UY29170A1 (es) Adeninas sustituidas y usos de las mismas
DK1809661T3 (da) Humant interferon-beta-mutein
UY28313A1 (es) Nonadepsipeptidos acilados
PA8806501A1 (es) Triazolotriazinas y triazolopirazinas y su uso
ECSP10010464A (es) Uso de ranolazina para el tratamiento de enfermedades cardiovasculares
CL2007001910A1 (es) Compuestos derivados de penem; composicion farmaceutica; y uso en el tratamiento de una infeccion bacteriana.
ATE477805T1 (de) 9a-carbamoyl-y-aminopropyl- und 9a-thiocarbamoyl- y-aminopropyl-azalide mit antimalaria-aktivität
UY29189A1 (es) Nonadepsipeptidos acilados ii
EA200602002A1 (ru) Применение спинозинов для заживления ран
EA201000864A1 (ru) Фенилоксетанильные производные
CL2008001613A1 (es) Compuestos macrociclicos; composicion farmaceutica; y uso en el tratamiento de una infeccion bacteriana.
ATE433459T1 (de) Desoxo-nonadepsipeptide
DK1713438T3 (da) Medicinsk sæbe
DE502005008925D1 (de) Substituierte nonadepsipeptide

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)